 SAN CARLOS, Calif., Feb. 02, 2021 GLOBE NEWSWIRE -- BioCardia, Inc. Nasdaq: BCDA a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today provides an update on its cell therapy product development and 2021 milestones. 